Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
ATOM MEDICAL has been recognized by MedTech Outlook Magazine as the exclusive recipient of “Top 20 Medtech Companies - 2023,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the MedTech Outlook research and editorial team based on insights from an interview with Mr. Ichiro Matsubara, CEO and President.
Mr. Ichiro Matsubara, CEO and PresidentThese initiatives are more than just business ventures; they represent ATOM MEDICAL’s dedication to tackling health disparities. The firm reallocates profits from various business sectors to fuel these humanitarian efforts, setting it apart from its industry peers.![]()
Through continual enhancement, our firm relentlessly pursues excellence in services and technology, striving for the well-being of every neonate
Company
ATOM MEDICAL
Management
Mr. Ichiro Matsubara, CEO and President
Description
ATOM MEDICAL is a Japanese company that specializes in the development and production of medical equipment for neonatal care, especially infant incubators. The company was founded in 1938 and has since become a leader in the field of neonatal and premature baby care.
Sito Web:
mythras.it
Amministratore:
Roberto Livio Mastronardi, co-fondatore
Descrizione:
Mythras è un team di tecnici specializzati nell'assistenza tecnica su strumentazione IVD, esperti nell'aiutare i responsabili di laboratorio a garantire la precisione, l'accuratezza e la conformità dei loro strumenti. È la scelta ideale per numerosi clienti e distributori, al servizio delle loro complesse esigenze di assistenza tecnica e ricondizionamento della strumentazione IVD.
Citazione:
“Siamo certificati ISO 9001:2015 per l'assistenza tecnica e il ricondizionamento della strumentazione analitica IVD.”
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
